Kyowa Pharmaceutical Overview
- Year Founded
-
1954
- Status
-
Acquired/Merged
- Employees
-
580
- Latest Deal Type
-
M&A
- Financing Rounds
-
3
- Investments
-
1
Kyowa Pharmaceutical General Information
Description
Manufacturer and supplier of pharmaceuticals intended to benefit the medical community and human health. The company's product portfolio mainly consists of a wide range of psychiatric and neurological products including psychotropics, hypnotics and sedatives, anxiolytics, antihypertensives, and vasodilators, along with hyperlipidemia, peptic ulcer, antiallergic, antidiabetic and allergic agents, enabling physicians to provide enhanced psychiatric and neurological treatments.
Contact Information
Website
www.kyowayakuhin.co.jpCorporate Office
- 27th floor, Nakanoshima Festival Tower West
- 3-2-4, Nakanoshima, Kita-ku
- Osaka, 530-0005
- Japan
Corporate Office
- 27th floor, Nakanoshima Festival Tower West
- 3-2-4, Nakanoshima, Kita-ku
- Osaka, 530-0005
- Japan
Kyowa Pharmaceutical Valuation & Funding
| Deal Type | Date | Amount | Valuation/ EBITDA |
Post-Val | Status | Debt |
|---|
Kyowa Pharmaceutical Related Research & Analysis
Explore institutional-grade private market research from our team of analysts.
-
Verticals
Kyowa Pharmaceutical Patents
Kyowa Pharmaceutical Recent Patent Activity
| Publication ID | Patent Title | Status | First Filing Date | Technology (CPC) | Citations |
|---|---|---|---|---|---|
| JP-2026115936-A | Rasagiline mesylate-containing pharmaceutical composition | Pending | 27-Dec-2024 | ||
| JP-2025120141-A | Method for producing sustained-release granule containing venlafaxine hydrochloride | Pending | 03-Feb-2024 | ||
| JP-2025105101-A | Pharmaceutical composition comprising guanfacine or pharmaceutically acceptable salt thereof | Pending | 28-Dec-2023 | ||
| JP-2025068996-A | Pharmaceutical composition containing lacosamide | Pending | 17-Oct-2023 | ||
| JP-2024007006-A | Venlafaxine hydrochloride-containing granules and method for producing the same | Pending | 05-Jul-2022 |
Kyowa Pharmaceutical Signals
Growth Rate
Growth
Size Multiple
Key Data Points
Similarweb Unique Visitors
Majestic Referring Domains
Kyowa Pharmaceutical Former Investors
| Investor Name | Investor Type | Holding | Investor Since | Participating Rounds | Contact Info |
|---|
Kyowa Pharmaceutical Investments (1)
Kyowa Pharmaceutical’s most recent deal was a PE Growth/Expansion with neurocare. The deal was made on 27-Jul-2020.
| Company Name | Deal Date | Deal Type | Deal Size | Industry | Lead Partner |
|---|---|---|---|---|---|
| neurocare | 27-Jul-2020 | PE Growth/Expansion | Other Healthcare Technology Systems |
Kyowa Pharmaceutical Affiliates
Subsidiaries (1)
| Name | Industry | Location | Year Founded |
|---|---|---|---|
| Kyowa Criticare | Atsugi City, Japan | 1945 |
Kyowa Pharmaceutical FAQs
-
When was Kyowa Pharmaceutical founded?
Kyowa Pharmaceutical was founded in 1954.
-
Where is Kyowa Pharmaceutical headquartered?
Kyowa Pharmaceutical is headquartered in Osaka, Japan.
-
What is the size of Kyowa Pharmaceutical?
Kyowa Pharmaceutical has 580 total employees.
-
What industry is Kyowa Pharmaceutical in?
Kyowa Pharmaceutical’s primary industry is Pharmaceuticals.
-
Is Kyowa Pharmaceutical a private or public company?
Kyowa Pharmaceutical is a Private company.
-
What is Kyowa Pharmaceutical’s current revenue?
The current revenue for Kyowa Pharmaceutical is .
-
Who are Kyowa Pharmaceutical’s investors?
Lupin and Unison Capital have invested in Kyowa Pharmaceutical.
-
When was Kyowa Pharmaceutical acquired?
Kyowa Pharmaceutical was acquired on 01-Mar-2024.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read more -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process
